Audio: US to resume J&J COVID vaccinations despite rare clot risk

4 years ago

https://digital-stage.newsnationnow.com/wp-content/uploads/sites/108/2021/04/JJ-resumes-use.mp3

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot.

WASHINGTON (NewsNation Now) — U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot.